Involvement of CB1 cannabinoid receptors in emotional behaviour

Psychopharmacology

Volumn 159, Issue 4, 2002, Pages 379-387

  Martin, Miquel ^a   Ledent, Catherine ^b   Parmentier, Marc ^b   Maldonado, Rafael ^a   Valverde, Olga ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Active avoidance; Cannabinoid; CB1 receptor; Chronic unpredictable mild stress; Depression like state; Resident intruder test

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR;

AGGRESSIVENESS; ANHEDONIA; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CONDITIONED REFLEX; CONTROLLED STUDY; DEPRESSION; EMOTION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS;

EID: 0036166628     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-001-0946-5     Document Type: Article

References (52)

1. Aggressiveness induced by marihuana and other psychotropic drugs in REM sleep deprived rats
2. Measurement of the three phases of muricidal behavior induced by delta 9-tetrahydrocannabinol in isolated, fasting rats
3. Cannabinoids: Influence on neurotransmitter uptake in rat brain synaptosomes
4. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors
5. Control of pain initiation by endogenous cannabinoids
6. Effects of smoked marijuana on human performance: A critical review
7. 9-tetrahydrocannabinol administration and schedule-induced aggression
8. Determination and characterization of a cannabinoid receptor in rat brain
9. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
10. Cannabinoid pharmacology
11. Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task
12. Mice deficient for delta and mu-opioid receptors exhibit opposing alterations of emotional responses
13. Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR 141716A
14. 9-tetrahydrocannabinol
15. Characterization and localization of cannabi-noid receptors in rat brain: A quantitative in vitro autoradiographic study
16. 9-tetrahydrocannabinol and psychoactive drugs: Effects on uptake of biogenic amines and on behaviour
17. Effects of apomorphine and diazepam in a quickly conditioned suppression in rats
18. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin
19. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
20. Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism
21. Spinal and supraspinal components of cannabinoid-induced antinociception
22. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta 9-tetrahydrocannabinol or anandamide
23. Modulation by fluoxetine of striatal dopamine release following delta-tetrahydrocannabinol: A microdialysis study in conscious rats
24. Opioid and cannabinoid receptor-mediated regulation of the increase in adreno-corticotropin hormone and corticosterone plasma concentrations induced by central administration of delta 9-tetrahydro-cannabinol in rats
25. Pharmacological and biochemical interactions between opioids and cannabinoids
26. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice
27. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
28. Cannabis: Effects on memory and the cholinergic limbic system
29. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine
30. D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration
31. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity
32. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat
33. Pharmacological characterisation of cannabinoids in the elevated plus maze
34. Enhancement of memory in cannabinoid CB1 receptor knockout mice
35. Effects of delta-9 tetrahydrocannabinol exposure on adrenal medullary function: Evidence of an acute effect and development of tolerance in chronic treatments
36. Corticotropin-releasing factor (CRF) antagonist {D-Phe12,Nle21,38,C alpha MeLeu37}CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats
37. Facilitation of avoidance learning by chlordiazepoxide-amphetamine combinations in mice
38. Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval
39. A second endogenous cannabinoid that modulates long-term potentiation
40. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism
41. Self-administration behaviour is maintained by the psychoactive ingredient of marijuana in squirrel monkeys
42. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
43. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice
44. The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCK-B receptor antagonist
45. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors
46. Cannabinoid withdrawal syndrome is reduced in preproenkephalin knock-out mice
47. Effect of hypothalamic injections of 5,7-dihydroxytryptamine on elicitation of mouse-killing in rats
48. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat
49. Cannabinoids in clinical practice
50. Animal models of depression: An overview
51. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation
52. Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects